Co-Diagnostics, Inc.
CODX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22,752 | $39,031 | $79,327 | $257,850 |
| - Cash | $2,937 | $14,917 | $22,974 | $88,607 |
| + Debt | $2,152 | $2,991 | $348 | $0 |
| Enterprise Value | $21,967 | $27,105 | $56,701 | $169,243 |
| Revenue | $3,915 | $6,812 | $34,218 | $97,886 |
| % Growth | -42.5% | -80.1% | -65% | – |
| Gross Profit | $2,916 | $2,627 | $28,737 | $86,311 |
| % Margin | 74.5% | 38.6% | 84% | 88.2% |
| EBITDA | -$38,704 | -$41,476 | -$10,309 | $46,400 |
| % Margin | -988.6% | -608.9% | -30.1% | 47.4% |
| Net Income | -$37,639 | -$35,333 | -$14,238 | $36,659 |
| % Margin | -961.4% | -518.7% | -41.6% | 37.5% |
| EPS Diluted | -1.24 | -1.2 | -0.45 | 1.23 |
| % Growth | -3.3% | -166.7% | -136.6% | – |
| Operating Cash Flow | -$29,155 | -$22,082 | $6,569 | $41,081 |
| Capital Expenditures | -$748 | -$1,365 | -$1,428 | -$669 |
| Free Cash Flow | -$29,903 | -$23,447 | $5,141 | $40,412 |